Clinical Trials Directory

Trials / Completed

CompletedNCT06956638

Bilirubin Levels to Diagnose Appendicitis and Predict Appendiceal Perforation

Predictors of Appendiceal Perforation and the Role of Total Bilirubin at Presentation: A Single Center Prospective Cross-sectional Study in Nepal

Status
Completed
Phase
Study type
Observational
Enrollment
98 (actual)
Sponsor
Nepalese Army Institute of Health Sciences · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to learn if serum bilirubin levels can aid in the diagnosis of acute appendicitis and predict appendiceal perforation

Detailed description

The study aims to assess hyperbilirubinemia: serum direct, indirect and total bilirubin to enhance the diagnostic accuracy of acute appendicitis. Also it aims to analyze different patient variables such as age, gender, duration of symptoms, leukocyte and neutrophil count, Alvarado score, presence of fever, nausea \& vomiting, peritonitis alongside serum total bilirubin level in patients with appendicitis and assess which variables can be taken as independent factors to predict appendiceal perforation.

Conditions

Interventions

TypeNameDescription
OTHERNon-interventionalNon-interventional study

Timeline

Start date
2022-07-16
Primary completion
2023-06-15
Completion
2025-03-12
First posted
2025-05-04
Last updated
2025-05-07

Locations

1 site across 1 country: Nepal

Source: ClinicalTrials.gov record NCT06956638. Inclusion in this directory is not an endorsement.

Bilirubin Levels to Diagnose Appendicitis and Predict Appendiceal Perforation (NCT06956638) · Clinical Trials Directory